Preminger leaving J&J Innovation

Michal Preminger is stepping down as Johnson & Johnson Innovation’s head of eastern North America. In a LinkedIn post, Preminger wrote that she will spend time on three “extracurricular passion projects” while considering her next career move.

Targeted protein degradation company Kymera Therapeutics Inc. (NASDAQ:KYMR) hired Noah Goodman as chief business officer. He was president and chief business officer at Nchroma Bio Inc., as well as its predecessor company Chroma Medicine Inc...